Sleep and sleepiness in the course of infections and of experimental immunomodulation in humans;Schlaf und schlafrigkeit im rahmen von infektionen und im rahmen experimenteller immunmodulation beim menschen

Somnologie

Volumn 4, Issue 2, 2000, Pages 68-78

  Pollmächer, Thomas ^a   Schuld, Andreas ^a   Kraus, Thomas ^a   Haack, Monika ^a   Hinze Selch, Dunja ^b   Mullington, Janet ^c  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cytokines; Endotoxin; Immune system; Lipopolysaccharides; Sleep

Indexed keywords

CYTOKINE; ENDOTOXIN; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROCORTISONE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; SEDATIVE AGENT; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ELECTROENCEPHALOGRAPHY; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; INFECTION; SLEEP; SOMNOLENCE;

EID: 0034128453     PISSN: 14329123     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-054X.2000.12700.x     Document Type: Article

References (96)

1. Aldrich MS: Narcolepsy. N Engl J Med 323: 389-394, 1990.
2. Altmann DM, Trowsdale J: Major histocompatibility complex structure and function. Curr Opin Immunol 2: 93-98, 1989.
3. Aristotle: Aristotle in twenty-three volumes, Vol. 8: On the soul parva naturalia on breath. English translation by Hett WS. Harvard University Press, Cambridge, MA and Heinemann, London, pp 316-345, 1975.
4. Barr CE, Mednick SA, Munk-Jorgensen P: Exposure to influenza epidemics during gestation and adult schizophrenia. A 40-year study. Arch Gen Psychiatry 47: 869-874, 1990.
5. Bauer J, Hohagen F, Gimmel E, Bruns F, Lis S, Krieger S, Ambach W, Guthmann A, Grunze H, Fritsch-Montero R, Weissbach A, Ganter U, Frommberger U, Riemann D, Berger M: Induction of cytokine synthesis and fever suppresses REM sleep and improves mood in patients with major depression. Biol Psychiatry 38: 611-621, 1995.
6. Benca RM, Quintans J: Sleep and host defenses: a review. Sleep 20: 1027-1037, 1997.
7. Bentivoglio M, Grassi-Zucconi G, Olsson T, Kristensson K: Trypanosoma brucei and the nervous system. Trends Neurosci 17: 325-329, 1994.
8. Buguet A, Bert J, Tapie P, Tabaraud F, Doua F, Lonsdorfer J, Bogui P, Dumas M: Sleep-wake cycle in human African trypanosomiasis. J Clin Neurophysiol 10: 190-196, 1993.
9. Bunnell DE, Horvath SM: Effects of body heating during sleep interruption. Sleep 8: 274-282, 1985.
10. Burrell R: Human responses to bacterial endotoxin. Circ Shock 43: 137-153, 1994.
11. Charron D: Molecular basis of human leukocyte antigen class II disease associations. Adv Immunol 48: 107-159, 1990.
12. Darko DF, Mitler MM, Henriksen SJ: Lentiviral infection, immune response peptides and sleep. Adv Neuroimmunol 5: 57-77, 1995.
13. Fang J, Wang Y, Krueger JM: Mice lacking the TNF 55 kDa receptor fail to sleep more after TNF? treatment. J Neurosci 17: 5949-5955, 1997.
14. Friess E, Wiedemann K, Steiger A, Holsboer F: The hypothalamic-pituitary-adrenocortical system and sleep in man. Adv Neuroimmunol 5: 111-125, 1995.
15. Ganguli R, Brar JS, Chengappa KN, Yang ZW, Nimgaonkar VL, Rabin BS: Autoimmunity in schizophrenia: a review of recent findings. Ann Med 25: 489-496, 1993.
16. Ganguli R, Rabin BS: Increased serum interleukin 2 receptor concentration in schizophrenic and brain-damaged subjects. Arch Gen Psychiatry 46: 292, 1989.
17. Ganguli R, Reynolds CF, Kupfer DJ: Electroencephalographic sleep in young, never-medicated schizophrenics. A comparison with delusional and nondelusional depressives and with healthy controls. Arch Gen Psychiatry 44: 36-44, 1987.
18. Gillin JC, Sitaram N, Wehr T, Duncan W, Post R, Murphy DL, Mendelson WB, Wyatt RJ, Bunney WE: Sleep and affective illness. In: Post RM, Ballenger JC (eds): Neurobiology of mood disorders. Williams and Wilkins, Baltimore, pp 157-189, 1984.
19. Guilleminault C, Mondini S: Mononucleosis and chronic daytime sleepiness. A long-term follow-up study. Arch Intern Med 146: 1333-1335, 1986.
20. Haack M, Hinze-Selch D, Fenzel T, Kraus T, Kühn M, Schuld A, Pollmächer T: Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis. J Psychiatr Res 33: 407-418, 1999.
21. Hartung T: Immunomodulation by colony-stimulating factors. Rev Physiol Biochem Pharmacol 136: 1-164, 1999.
22. Hermann DM, Mullington J, Hinze-Selch D, Schreiber W, Galanos C. Pollmächer T: Endotoxin-induced changes in sleep and sleepiness during the day. Psychoneuroendocrinology 23: 427-437, 1998.
23. Hinze-Selch D, Mullington J, Orth A, Lauer CJ, Pollmächer T: Effects of clozapine on sleep: a longitudinal study. Biol Psychiatry 42: 260-266, 1997.
24. Hinze-Selch D, Wetter TC, Zhang Y, Lu HC, Albert ED, Mullington J, Wekerle H, Holsboer F, Pollmächer T: In vivo and in vitro immune variables in patients with narcolepsy and HLA-DR2 matched controls. Neurology 50: 1149-1152, 1998.
25. Holsboer F: Neuroendocrinology of mood disorders. In: Bloom F, Kupfer D (eds): Neuropsychopharmacology. Raven Press, New York, pp 957-969, 1995.
26. Home JA, Staff LH: Exercise and sleep: body-heating effects. Sleep 6: 36-46, 1983.
27. Hrushesky WJ, Langevin T, Kim YJ, Wood PA: Circadian dynamics of tumor necrosis factor alpha (cachectin) lethality. J Exp Med 180: 1059-1065, 1994.
28. Imeri L, Opp MR, Krueger JM: An IL-1 receptor and an IL-1 receptor antagonist attenuate muramyl dipeptide- and IL-1-induced sleep and fever. Am J Physiol 265: R907-R913, 1993.
29. Irwin M, Smith TL, Gillin JC: Electroencephalographic sleep and natural killer activity in depressed patients and control subjects. Psychosom Med 54: 10-21, 1992.
30. Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO: Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor ?: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci U S A 87: 1233-1237, 1990.
31. Jacobson JM, Greenspan JS, Spritzler J, Ketter N, Fahey JL, Jackson JB, Fox L, Chernoff M, Wu AW, MacPhail LA, Vasquez GJ, Wohl DA: Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. N Engl J Med 336: 1487-1493, 1997.
32. Jus K, Bouchard M, Jus AK, Villeneuve A, Lachance R: Sleep EEG studies in untreated, long-term schizophrenic patients. Arch Gen Psychiatry 29: 386-390, 1973.
33. Karacan I, Wolff SM, Williams RL, Hursch CJ, Webb WB: The effects of fever on sleep and dream patterns. Psychosomatics 9: 331-339, 1968.
34. Kessler S: Genetic factors in narcolepsy. In: Guillerminault C, Dement WC, Passouant P (eds): Narcolepsy, Spectrum, New York, pp 285-302, 1976.
35. Kirch DG: Infection and autoimmunity as etiologic factors in schizophrenia: a review and reappraisal. Schizophr Bull 19: 355-370. 1993.
36. Kluger MJ: Fever: role of pyrogens and cryogens. Physiol Rev 71: 93-127, 1991.
37. Korth C, Mullington J, Schreiber W, Pollmächer T: Influencé of endotoxin on daytime sleep in humans. Infect Immun 64: 1110-1115, 1996.
38. Krueger JM, Takahashi S, Kapás L, Bredow S, Roky R, Fang JD, Floyd R, Renegar KB, Guha-Thakurta N, Novitsky S, Obál F: Cytokines in sleep regulation. Adv Neuroimmunol 5: 171-188, 1995.
39. Krupp LB, Mendelson WB, Friedman R: An overview of chronic fatigue syndrome. J Clin Psychiatry 52: 403-410, 1991.
40. Kubicki S, Henkes H, Alm D, Scheuler W, Pohle HD, Ruf B, Könneke J: Schlafpolygraphische Daten von AIDS-Patienten. EEG-EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb 20: 288-294, 1989.
41. Lambore S, McSherry J, Kraus AS: Acute and chronic symptoms of mononucleosis. J Fam Pract 33: 33-37, 1991.
42. Lauer CJ, Riemann D, Wiegand M, Berger M: From early to late adulthood: Changes in EEG sleep of depressed patients and healthy volunteers. Biol Psychiatry 29: 979-993, 1991.
43. Lauer CJ, Schreiber W, Pollmächer T, Holsboer F, Krieg JC: Sleep in schizophrenia: a polysomnographic study on drug-naive patients. Neuropsychopharmacology 16: 51-60, 1997.
44. Lepage V, Lamm LU, Charron D: Molecular aspects of HLA class II and some autoimmune diseases. Eur J Immunogenet 20: 153-164, 1993.
45. Levine J, Susnovski M, Handzel ZT, Leykin I, Shinitzky M: Treatment of schizophrenia with an immunosuppressant. Lancet 344: 59-60, 1994.
46. Lyketsos CG, Federman EB: Psychiatric disorders and HIV infection: impact on one another. Epidemiol Rev 17: 152-164, 1995.
47. Matsuki K, Grumet FC, Lin X, Gelb M, Guilleminault C, Dement WC, Mignot E: DQ (rather than DR) gene marks susceptibility to narcolepsy. Lancet 339: 1052, 1992.
48. McAllister CG, Rapaport MH, Pickar D, Podruchny TA, Christison G, Alphs LD, Paul SM: Increased numbers of CDS+ B lymphocytes in schizophrenic patients. Arch Gen Psychiatry 46: 890-894, 1989.
49. Mignot E, Lin X, Hesla PE, Dement WC, Guilleminault C, Grumet FC: A novel HLA DR17.DQ1 (DQA1-0102/DQB1-0602 positive) haplotype predisposing to narcolepsy in caucasians. Sleep 16: 764-765, 1993.
50. Mignot E, Tafti M, Dement WC, Grumet FC: Narcolepsy and immunity. Adv Neuroimmunol 5: 23-37, 1995.
51. Moldofsky H: Sleep, neuroimmune and neuroendocrine functions in fibromyalgia and chronic fatigue syndrome. Adv Neuroimmunol 5: 39-56, 1995.
52. Mullington J, Korth C, Hermann DM, Orth A, Galanos C, Holsboer F, Pollmächer T: Dose-dependent effects of endotoxin on human sleep. Am J Physiol 278: R947-955: 2000.
53. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E: Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355: 39-40, 2000.
54. Norman SE, Chediak AD, Freeman C, Kiel M, Mendez A, Duncan R, Simoneau J, Nolan B: Sleep disturbances in men with asymptomatic human immunodeficiency (HIV) infection. Sleep 15: 150-155, 1992.
55. Norman SE, Chediak AD, Kiel M, Cohn MA: Sleep disturbances in HIV-infected homosexual men. AIDS 4: 775-781, 1990.
56. O'Callaghan E, Sham PC, Takei N, Murray G, Glover G, Hare EH, Murray RM: The relationship of schizophrenic births to 16 infectious diseases. Br J Psychiatry 165: 353-356, 1994.
57. Opp M, Obál F Jr, Cady AB, Johannsen L, Krueger JM: Interleukin-6 is pyrogenic but not somnogenic. Physiol Behav 45: 1069-1072, 1989.
58. Opp MR, Krueger JM: Anti-interleukin-1? reduces sleep and sleep rebound after sleep deprivation in rats. Am J Physiol 266: R688-R695, 1994.
59. Pantaleo G, Graziosi C, Fauci AS: New concepts in the immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 328: 327-335, 1993.
60. Pappenheimer JR, Koski G, Fencl V, Karnovsky ML, Krueger J: Extraction of sleep-promoting factor S from cerebrospinal fluid and from brains of sleep-deprived animals. J Neurophysiol 38: 1299-1311, 1975.
61. Parrillo JE: Pathogenetic mechanisms of septic shock. N Engl J Med 328: 1471-1477, 1993.
62. Pentreath VW: Neurobiology of sleeping sickness. Parasitol Today 5: 215-218, 1989.
63. Pollmächer T, Geisler P, Schulz H: Der multiple Einschlaflatenz-Test (MSLT) in der Differentialdiagnose der Narkolepsie. Psycho 12: 378-379, 1986.
64. Pollmächer T, Hinze-Selch D, Mullington J: Effects of clozapine on plasma cytokine and soluble cytokine receptor levels. J Clin Psychopharmacol 16: 403-409, 1996.
65. Pollmächer T, Holsboer F: Sleep-wake disturbances in HIV-infected patients - a potential model of the interactions between sleep and the immune system. Sleep Research Society Bulletin 2: 37-42, 1996.
66. Pollmächer T, Korth C, Mullington J, Schreiber W, Sauer J, Vedder H, Galanos C, Holsboer F: Effects of granulocyte colony-stimulating factor on plasma cytokine and cytokine receptor levels and on the in vivo host response to endotoxin in healthy men. Blood 87: 900-905, 1996.
67. Pollmächer T, Mullington J, Korth C, Hinze-Selch D: Influence of host defense activation on sleep in humans. Adv Neuroimmunol 5: 155-169, 1995.
68. Pollmächer T, Mullington J, Korth C, Schreiber W, Hermann D, Orth A, Galanos C, Holsboer F: Diurnal variations in the human host response to endotoxin. J Infect Dis 174: 1040-1045, 1996.
69. Pollmächer T, Mullington J, Lauer CJ: REM sleep disinhibition at sleep onset: a comparison between narcolepsy and depression. Biol Psychiatry 42: 713-720, 1997.
70. Pollmächer T, Schreiber W, Gudewill S, Vedder H, Fassbender K, Wiedemann K, Trachsel L, Galanos C, Holsboer F: Influence of endotoxin on nocturnal sleep in humans. Am J Physiol 264: R1077-R1083, 1993.
71. Pollmächer T, Schulz H, Geisler P, Kiss E, Albert ED, Schwarzfischer F: DR2-positive monozygotic twins discordant for narcolepsy. Sleep 13: 336-343, 1990.
72. Rapaport MH, McAllister CG, Pickar D, Nelson DL, Paul SM: Elevated levels of soluble interleukin 2 receptors in schizophrenia. Arch Gen Psychiatry 46: 291-292, 1989.
73. Reynolds CF, Kupfer DJ: Sleep research in affective illness: state of the an circa 1987. Sleep 10: 199-215, 1987.
74. Rietschel ET, Kirikae T, Schade FU, Mamat U, Schmidt G, Loppnow H, Ulmer AJ, Zähringer U, Seydel U, Di Padova F, Schreiber M, Brade H: Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 8: 217-225, 1994.
75. Schuld A, Mullington J, Hermann D, Hinze-Selch D, Fenzel T, Holsboer F, Pollmächer T: Effects of granulocyte colony-stimulating factor on night sleep in humans Am J Physiol 276: R1149-R1155, 1999.
76. Smith A: Sleep, colds, and performance. In: Broughton RJ, Oglivie RD (eds): Sleep, arousal, and performance. Birkhäuser, Boston, pp 233-242, 1992.
77. Späth-Schwalbe E, Hansen K, Schmidt F, Schrezenmeier H, Marshall L, Burger K, Fehm HL, Born J: Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. J Clin Endocrinol Metab 83: 1573-1579, 1998.
78. Stein M, Miller AH, Trestman RL: Depression and the immune system. In: Ader R, Cohen N, Felten D (eds): Psychoneuroimmunology. 2nd edition. Academic Press, San Diego, pp 897-930, 1991.
79. Steward WP: Granulocyte and granulocyte-macrophage colony-stimulating factors. Lancet 342: 153-157, 1993.
80. Tafti M, Nishino S, Aldrich MS, Liao W, Dement WC, Mignot E: Major histocompatibility class II molecules in the CNS: increased microglial expression at the onset of narcolepsy in a canine model. J Neurosci 16; 4588-4595, 1996.
81. Takahashi S, Kapás L, Fang JD, Krueger JM: An anti-tumor necrosis factor antibody suppresses sleep in rats and rabbits. Brain Res 690: 241-244, 1995.
82. Takahashi S, Tooley DD, Kapás L, Fang JD, Seyer JM, Krueger JM: Inhibition of tumor necrosis factor in the brain suppresses rabbit sleep. Eur J Physiol 431: 155-160, 1995.
83. Tandon R, Shipley JE, Taylor S, Greden JF, Eiser A, DeQuardo J, Goodson J: Electroencephalographic sleep abnormalities in schizophrenia. Relationship to positive/negative symptoms and prior neuroleptic treatment. Arch Gen Psychiatry 49: 185-194, 1992.
84. Toth LA: Sleep, sleep deprivation and infectious disease: studies in animals. Adv Neuroimmunol 5: 79-92, 1995.
85. Trachsel L, Schreiber W, Holsboer F, Pollmächer T: Endotoxin enhances EEG alpha and beta power in human sleep. Sleep 17: 132-139, 1994.
86. Turnbull AV, Rivier C: Regulation of the HPA axis by cytokines. Brain Behav Immun 9: 253-275, 1995.
87. von Economo C: Die Enzephalitis lethargica. Ihre Nachkrankheiten und ihre Behandlung. Urban & Schwarzenberg, Berlin, 1929.
88. von Econome C: Sleep as a problem of localization. J Nerv Ment Dis 71: 249-259, 1930.
89. Watson CG, Kucala T, Tilleskjor C, Jacobs L: Schizophrenic birth seasonality in relation to the incidence of infectious diseases and temperature extremes. Arch Gen Psychiatry 41: 85-90, 1984.
90. Weisse CS: Depression and immunocompetence: a review of the literature. Psychol Bull 111: 475-489, 1992.
91. Westphal O, Westphal U, Sommer T: The history of pyrogen research. In: Schlesinger D (ed): Microbiology - 1977. American Society for Microbiology, Washington, DC, pp 221-238, 1978.
92. Weyand CM, Goronzy JJ: Functional domains on HLA-DR molecules: implications for the linkage of HLA-DR genes to different autoimmune diseases. Clin Immunol Immunopathol 70: 91-98, 1994.
93. Whelton CL, Salit I, Moldofsky H: Sleep, Epstein-Barr virus infection, musculoskeletal pain, and depressive symptoms in chronic fatigue syndrome. J Rheumatol 19: 939-943, 1992.
94. White JL, Darko DF, Brown SJ, Miller JC, Hayduk R, Kelly T, Mitler MM: Early central nervous system response to HIV infection: sleep distortion and cognitive-motor decrements. AIDS 9: 1043-1050, 1995.
95. Wiegand M, Möller AA, Schreiber W, Krieg JC, Fuchs D, Wachter H, Holsboer F: Nocturnal sleep EEG in patients with HIV infection. Eur Arch Psychiatry Clin Neurosci 240: 153-158, 1991.
96. Wolkenstein P, Latarjet J, Roujeau JC, Duguet C, Boudeau S, Vaillant L, Maignan M, Schuhmacher MH, Milpied B, Pilorget A, Bocquet H, Brun-Buisson C, Revuz J: Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis. Lancet 352: 1586-1589, 1998.